$35.29
▲ +2.0% Today
as of Aug 5, 16:53 ET
Last 30 days
Recent Press Releases & News
ROIV: What does Argus have to say about ROIV?
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
ROIV: Lowering target price to $37.00
Overview
52-week range
$11
$33
100% of range
Avg surprise (last 4)
-0.3%
Avg reaction (last 2)
+10.6%
100% positive
Latest IV / EM
65%
EM ±10.8% · $35 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 20, 2026 | Mar/2026 | $-0.46 | $-0.38 | -21.1% | -48.4% | +14.9% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $-0.38 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.17 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-0.30 | $-0.31 | +3.2% | — | — | earnings |
| Thu May 29, 2025 | Mar/2025 | $-0.31 | $-0.23 | -34.8% | — | +6.4% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $0.23 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.31 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.12 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $6.03 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.40 | — | — | — | — | financials |
| Wed Jun 28, 2023 | Mar/2023 | $-0.20 | $-0.41 | +51.2% | — | — | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | BMO | -$0.45 | -$0.30 | -50.0% |
Financials
Income statement (quarterly)
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | — | $9M | $4M | $8M | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-339M | $-306M | $-285M | — | $-274M | $-342M | $-102M | — |
| Net income | $-266M | $-114M | $-223M | — | $169M | $-230M | $95M | — |
| EPS (diluted) | $-0.38 | $-0.17 | $-0.33 | — | $0.23 | $-0.31 | $0.12 | — |
Balance sheet (quarterly)
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.48B | $1.24B | $1.24B | $2.72B | $1.99B | $1.96B | $5.68B | $6.49B |
| Inventory | — | — | — | — | — | — | $34M | $35M |
| Total current assets | $4.66B | $4.51B | $4.62B | $5.00B | $5.36B | $5.80B | $6.00B | $6.73B |
| Total assets | $5.23B | $5.06B | $5.03B | $5.44B | $5.79B | $6.21B | $6.50B | $7.22B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $251M | $257M | $217M | $250M | $256M | $626M | $601M | $774M |
| Total equity | $4.27B | $4.36B | $4.35B | $4.69B | $5.19B | $5.15B | $5.44B | $5.97B |